Long-term outcomes of switching to BIC/FTC/TAF with or without prior INSTI experience: real-life data from a monocentric cohort of ART-experienced people with HIV

Key Points

• The aim is to assess the long-term outcomes of switching to BIC/FTC/TAF in ART-experienced individuals with or without INSTI experience.
• Monocentric cohort study design
• Sample of ART-experienced individuals
• Evaluation of switch outcomes over time
• Assessment of safety and lipid profiles
• BIC/FTC/TAF demonstrated durable efficacy and safety
• The regimen was well tolerated by individuals without prior INSTI experience
• Results indicate favorable lipid profiles when switching to BIC/FTC/TAF